Results of cytogenetics analysis*(n = 232)
. | Frequency . |
|---|---|
| Favorable | |
| t(15;17)(q22;q11-12) | 2 |
| inv(16)(p13q22) | 1 |
| Intermediate | |
| Normal* | 104 |
| + 8† | 13 |
| Others | 5 |
| Unfavorable | |
| del(5)(q12-31-q31-35)‡ | 10 |
| del(5)(q13q33)‡ | 9 |
| - 7‡ | 9 |
| del(7)(q22)‡ | 2 |
| del(7)(q32)‡ | 1 |
| del(20)(q11-13) | 4 |
| del(20)(q11) | 2 |
| + 8§ | 6 |
| Others | 45 |
| Unknown | 19 |
. | Frequency . |
|---|---|
| Favorable | |
| t(15;17)(q22;q11-12) | 2 |
| inv(16)(p13q22) | 1 |
| Intermediate | |
| Normal* | 104 |
| + 8† | 13 |
| Others | 5 |
| Unfavorable | |
| del(5)(q12-31-q31-35)‡ | 10 |
| del(5)(q13q33)‡ | 9 |
| - 7‡ | 9 |
| del(7)(q22)‡ | 2 |
| del(7)(q32)‡ | 1 |
| del(20)(q11-13) | 4 |
| del(20)(q11) | 2 |
| + 8§ | 6 |
| Others | 45 |
| Unknown | 19 |
Percentage of patients in each grouping are as follows: favorable, 1%; intermediate, 53%; unfavorable, 38%; and unknown, 8%. Results are based on Southwest Oncology Group (SWOG) classification.22
45% of all patients analyzed for cytogenetics.
6% of all patients analyzed for cytogenetics.
Patients with these 5 unfavorable cytogenetics (deletions of whole or part of chromosomes 7 or 5) compose 13% of all patients analyzed for cytogenetics.
Associated with del(7).